JP2022543655A5 - - Google Patents

Info

Publication number
JP2022543655A5
JP2022543655A5 JP2022507561A JP2022507561A JP2022543655A5 JP 2022543655 A5 JP2022543655 A5 JP 2022543655A5 JP 2022507561 A JP2022507561 A JP 2022507561A JP 2022507561 A JP2022507561 A JP 2022507561A JP 2022543655 A5 JP2022543655 A5 JP 2022543655A5
Authority
JP
Japan
Prior art keywords
composition according
mir
subject
administration step
radiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022507561A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022543655A (ja
JP7642611B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/045026 external-priority patent/WO2021026247A1/en
Publication of JP2022543655A publication Critical patent/JP2022543655A/ja
Publication of JP2022543655A5 publication Critical patent/JP2022543655A5/ja
Priority to JP2025029508A priority Critical patent/JP2025098011A/ja
Application granted granted Critical
Publication of JP7642611B2 publication Critical patent/JP7642611B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022507561A 2019-08-05 2020-08-05 放射線曝露を処置するためのセピアプテリン及びその代謝産物の使用 Active JP7642611B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025029508A JP2025098011A (ja) 2019-08-05 2025-02-26 放射線曝露を処置するためのセピアプテリン及びその代謝産物の使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962882937P 2019-08-05 2019-08-05
US62/882,937 2019-08-05
PCT/US2020/045026 WO2021026247A1 (en) 2019-08-05 2020-08-05 Use of sepiapterin and metabolites thereof to treat radiation exposure

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025029508A Division JP2025098011A (ja) 2019-08-05 2025-02-26 放射線曝露を処置するためのセピアプテリン及びその代謝産物の使用

Publications (3)

Publication Number Publication Date
JP2022543655A JP2022543655A (ja) 2022-10-13
JP2022543655A5 true JP2022543655A5 (https=) 2023-08-15
JP7642611B2 JP7642611B2 (ja) 2025-03-10

Family

ID=72148243

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022507561A Active JP7642611B2 (ja) 2019-08-05 2020-08-05 放射線曝露を処置するためのセピアプテリン及びその代謝産物の使用
JP2025029508A Pending JP2025098011A (ja) 2019-08-05 2025-02-26 放射線曝露を処置するためのセピアプテリン及びその代謝産物の使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025029508A Pending JP2025098011A (ja) 2019-08-05 2025-02-26 放射線曝露を処置するためのセピアプテリン及びその代謝産物の使用

Country Status (21)

Country Link
US (1) US20220273661A1 (https=)
EP (2) EP4454712A3 (https=)
JP (2) JP7642611B2 (https=)
CN (2) CN114555090B (https=)
AU (1) AU2020324435B2 (https=)
BR (1) BR112022002029A2 (https=)
CA (1) CA3146477A1 (https=)
DK (1) DK4009978T3 (https=)
ES (1) ES2994060T3 (https=)
FI (1) FI4009978T3 (https=)
HR (1) HRP20241653T1 (https=)
HU (1) HUE069012T2 (https=)
IL (1) IL290321B1 (https=)
LT (1) LT4009978T (https=)
MX (1) MX2022001535A (https=)
PL (1) PL4009978T3 (https=)
PT (1) PT4009978T (https=)
RS (1) RS66096B1 (https=)
SI (1) SI4009978T1 (https=)
SM (1) SMT202500089T1 (https=)
WO (1) WO2021026247A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA46973A (fr) 2016-11-29 2019-10-09 Censa Pharmaceuticals Inc Polymorphes de sépiaptérine et leurs sels
MA46972A (fr) 2016-11-29 2019-10-09 Censa Pharmaceuticals Inc Forme polymorphe de sépiaptérine
JP7811085B2 (ja) 2017-09-01 2026-02-04 ピーティーシー セラピューティクス エムピー,インコーポレイテッド セピアプテリンを含む医薬組成物及びその使用
FI3801536T3 (fi) 2018-05-30 2024-08-29 Ptc Therapeutics Mp Inc Sepiapteriinin antaminen ilman ruokaa käytettäväksi menetelmässä sepiapteriinin plasma-altistuksen lisäämiseksi
EP3801534B1 (en) 2018-05-30 2026-02-18 PTC Therapeutics MP, Inc. Treatment of phenylketonuria with sepiapterin
IL290321B1 (en) * 2019-08-05 2026-04-01 Ptc Therapeutics Inc Use of spiapterin and its metabolites for radiation exposure treatment

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5910304A (en) 1982-12-13 1999-06-08 Texas A&M University System Low-dose oral administration of interferons
CA1320905C (en) 1986-11-06 1993-08-03 Joseph M. Cummins Treatment of immuno-resistant disease
US6036949A (en) 1998-03-05 2000-03-14 Amarillo Biosciences, Inc. Treatment of fibromyalgia with low doses of interferon
WO2005048926A2 (en) 2003-11-13 2005-06-02 The General Hospital Corporation Methods for treating pain
KR20070084270A (ko) 2004-11-17 2007-08-24 바이오마린 파머수티컬 인크. 안정한 정제 제형물
TWI359019B (en) * 2006-08-14 2012-03-01 Merck Eprova Ag Use of folates for the prevention and treatment of
MX379061B (es) 2013-09-13 2025-03-04 Bioventures Llc Preparacion y uso de una composicion para la prevencion y mitigacion de los efectos de la radiacion.
CN106794197A (zh) 2014-10-02 2017-05-31 西托索尔本茨公司 经胃肠施用的多孔消化道吸着剂聚合物用于预防或治疗辐射诱导的黏膜炎、食管炎、小肠炎、结肠炎和胃肠急性放射综合征的用途
MA46973A (fr) 2016-11-29 2019-10-09 Censa Pharmaceuticals Inc Polymorphes de sépiaptérine et leurs sels
MA46972A (fr) 2016-11-29 2019-10-09 Censa Pharmaceuticals Inc Forme polymorphe de sépiaptérine
JP7811085B2 (ja) 2017-09-01 2026-02-04 ピーティーシー セラピューティクス エムピー,インコーポレイテッド セピアプテリンを含む医薬組成物及びその使用
AU2019277372B2 (en) 2018-05-30 2024-12-19 Ptc Therapeutics Mp, Inc. Pharmaceutically acceptable salts of sepiapterin
IL290321B1 (en) * 2019-08-05 2026-04-01 Ptc Therapeutics Inc Use of spiapterin and its metabolites for radiation exposure treatment
CN110354133A (zh) * 2019-08-26 2019-10-22 鞍山市肿瘤医院 四氢生物蝶呤的应用及药物

Similar Documents

Publication Publication Date Title
JP2022543655A5 (https=)
FI4009978T3 (fi) Sepiapteriiinin ja sen metaboliittien käyttö säteilyaltistuksen hoitoon
KR20100096108A (ko) 건성 점막 치료용 오스모라이트-함유 제제
ITMI20130075A1 (it) Combinazione orale per la prevenzione e il trattamento di patologie vescicali, pelviche e dell¿apparato uro-genitale
CN104225246B (zh) 一种口腔溃疡膜剂及其制备方法
CN103908484A (zh) 一种用于治疗类风湿性关节炎的雷公藤涂膜剂及其制备方法
WO2018137319A1 (zh) 大叶清香桂的应用,治疗皮肤病的中药膏剂、制备方法及其应用
CN107441071B (zh) 一种芳姜黄酮在制备治疗和/或预防银屑病药物中的应用
WO2024011800A1 (zh) 一种治疗咳嗽变异性哮喘的中药组合物及其制备方法
CN111249328A (zh) 一种复方口腔溃疡贴膜及其制备方法
US6998142B2 (en) Composition and method for the prevention and treatment of asthma
CN115227772B (zh) 一种用于改善细颗粒物诱导肺损伤的中药组方
CN105456240B (zh) 氨溴索沙丁胺醇气雾剂
WO2018219189A1 (zh) 头孢美唑在制备预防/治疗肺动脉高压药物中的应用
CN105362226B (zh) 氨溴索沙丁胺醇气雾剂的制备方法
WO2018219188A1 (zh) 头孢米诺在制备预防/治疗肺动脉高压药物中的应用
CN110251629A (zh) 一种治疗哮喘的中药组合及其应用
JP7579356B2 (ja) Covid-19の治療または予防用ペプチド
CN110179884B (zh) 一种用于感染性皮炎的酊剂及其制备方法和应用
CN105326790B (zh) 氨溴索沙丁胺醇溶液剂的制备方法
CN105326789A (zh) 氨溴索沙丁胺醇溶液剂
JP7618241B2 (ja) 一酸化窒素ドナー(noドナー)として使用するためのキトサン硝酸塩
CN101797258A (zh) 含有口服糖皮质激素和口服支气管扩张剂的药物组合物
JP2024516712A5 (https=)
CN116942727A (zh) 青钱柳提取物在制备用于治疗溃疡性结肠炎的药物中的应用